Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q1 FY21 Earnings Presentation
34 slides from Aster Dm Healthcare's earnings presentation, Aug 12, 2020
Slide 1: Cover letter to stock exchanges
August 12, 2020 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051
Slide 2: Investor Presentation – For the quarter ended 30th June 2020
Investor Presentation – For the quarter ended 30th June 2020 1
Slide 3: Disclaimer
Disclaimer ❑ This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Aster – An Integrated Healthcare Provider
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 3
Slide 5: Aster DM Healthcare – Business Overview
Aster DM Healthcare – Business Overview HOSPITALS One of Largest Private INSTALLED CAPACITY BEDS healthcare service providers GCC: 1,165 GCC: 13 4,858 26 India: 3,693 India: 13 operating in Asia (GCC & India) PATIENT VISITS – FY21 Q1 Present in 7 Countries CLINICS (UAE, Saudi Arabia, Qatar, Oman, ~3
Slide 6: Aster DM Healthcare – Financial Overview
Aster DM Healthcare – Financial Overview Note: 1. Revenue and EBITDA shown above excludes other income; 5 2. Above shown percentage of revenue and EBITDA by hospitals, clinics and pharmacies are calculated based on gross segmental numbers before allocation of inter-segment revenue and unallocated co
Slide 7: Geographical Footprint
Geographical Footprint Hospitals – 13 GCC Clinics – 107 Pharmacies – 238 Hospitals – 13 Clinics – 9 INDIA United Arab Emirates Kerala Medcare Hospital, Dubai Aster Medcity, Kochi Medcare Orthopaedics and Spine Hospital Aster MIMS, Calicut Aster Hospital Mankhool Aster MIMS, Kottakkal Medcare Women &
Slide 8: Hospitals List
Hospitals List C ommenc ement/ B ed Operational Owned Capacity Operational Hos pitals - GC C L oc ation Ac quis ition Year C apac ity B eds /L eas ed Geography Medcare Hospital Dubai, UAE 2007 64 55 Leased Beds Beds Al Raffah Hospital Muscat, Oman 2009 86 72 Leased GCC 1,165 971 Al Raffah Hospital S
Slide 9: Pipeline Projects
Pipeline Projects Owned / Hospitals - GCC Location Type Planned Beds Expected Completion Year Present Status Leased/O&M Aster Hospital Sharjah, UAE Greenfield 80 Q4 FY 2021 Construction Leased Aster Hospital Muscat, Oman Greenfield (Relocation) 145 Temporary Hold Leased Aster Hospital International
Slide 10: The Aster DM Healthcare Edge
The Aster DM Healthcare Edge Aster DM – A Healthcare Ecosystem • Presence across hospitals, clinics & pharmacies and providing primary, secondary and tertiary/ quaternary care • Strategic and sizeable network of clinics enable patient feeder structure Differentiated Asset-light Business Model in GCC
Slide 11: Aster DM Healthcare - Evolution
Aster DM Healthcare - Evolution Building the foundations New geographies, segments Brand “Aster” was formed, private equity Robust Growth across all segments and and service offerings investment, further expansion geographies; Rapid Expansion in India 2015: First clinic in Bahrain and in the Philipp
Slide 12: Robust Growth Over Last 5 Years
ROBUST GROWTH OVER LAST 5 YEARS ..Coupled with capacity creation for further growth, which resulted in an extensive geographical footprint # of Units FY15 FY16 FY17 FY18 FY19 FY20 FY21 Q1 Hospitals 14 13 18 19 24 25 26 Clinics 69 87 96 101 114 117 116 Pharmacies 166 180 202 207 219 238 238 Total 249
Slide 13: Aster – An Integrated Healthcare Provider
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 12
Slide 14: Aster - An Integrated Healthcare Provider
Aster - An Integrated Healthcare Provider FY20 Operational Information 950+ 1,95,000+ Cardiovascular IP Discharges Surgeries ~5.8 mn 14,900+ 900+ Clinic OPD Visits General Bariatric Surgeries Surgeries Clinics $ 1 ₹6 0% 2,300+ Joint 1,400+ ~ 9.8 mn Replacements Spine Surgeries Pharmacy Visits 14,000
Slide 15: Aster – A Healthcare Ecosystem
Aster – A Healthcare Ecosystem ▪ Aster, over 30 years, has created a healthcare eco-system across two geographical regions ▪ In GCC region, Aster’s primary care clinics act as the initial touch-points in the patient journey, while pharmacies and hospitals continue the care ▪ For complex tertiary car
Slide 16: GCC Healthcare – Unique Traits
GCC Healthcare – Unique Traits Healthcare market in GCC states have developed certain unique traits due to the higher expat and working age population Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) ➢ Due to lower % of older population requirement of tertiary and quaternar
Slide 17: Aster - Awards & Service Excellence
Aster - Awards & Service Excellence JCI Accreditation Padma Shri Award AHPI Awards Medcare Hospital Dubai, Medcare Dr. Azad Moopen, Chairman & Managing Medcity, CMI, MIMS Calicut, WIMS, Orthopedics and Spine Hospitals, Medcare Director – Aster DM Healthcare received Aadhar, Medcare , Medcare Ortho,
Slide 18: Key Highlights – FY21 Q1 (GCC clinical)
Key Highlights – FY21 Q1 Clinical Highlights - GCC ➢ Emergency Trauma Laparotomy performed on a 32-year-old male patient at Aster Hospital, Qusais, Dubai ➢ Saudi Arabian patient successfully extubated and fitted with ICD pacemaker at Aster Sanad Hospital, KSA ➢ Limb recovery surgery conducted on HIV
Slide 19: Key Highlights – FY21 Q1 (India clinical)
Key Highlights – FY21 Q1 Clinical Highlights - India ➢ Kerala’s first complex spine surgery using 3D printed patient specific surgical guides performed at Aster MIMS, Calicut ➢ A 5-day-old new born, diagnosed with Cervical Myelomeningocele became the youngest patient to be treated for this condition
Slide 20: Operational and Financial Overview
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 19
Slide 21: Revenue and Profitability Snapshot – FY21 Q1
Revenue and Profitability Snapshot – FY21 Q1 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) ▪ Constant currency growth of Revenue and EBITDA is ~-19% and ~-41% respectively Notes: 1. Above financials are presented in Rs. Crore 2. Percentages mentioned inside the bars are % to rev
Slide 22: Geography-wise Financial – Snapshot
Geography-wise Financial – Snapshot GCC INDIA CONSOLIDATED FY20 Q1 FY21 Q1 FY20 Q1 FY21 Q1 FY20 Q1 FY21 Q1 Revenue (₹) 1,658 Cr 1,462 Cr 370 Cr 299 Cr 2,029 Cr 1,761 Cr EBITDA (₹) 191 Cr 130 Cr 33 Cr 13 Cr 224 Cr 143 Cr PAT (₹) 19 Cr -44 Cr -16 Cr -39 Cr 3 Cr -83 Cr Notes: 1. Revenue and EBITDA show
Slide 23: Geography-wise Business – Snapshot
Geography-wise Business – Snapshot GCC INDIA CONSOLIDATED FY20 Q1 FY21 Q1 FY20 Q1 FY21 Q1 FY20 Q1 FY21 Q1 Total Capacity Beds 1,101 1,165 3,693 3,693 4,794 4,858 Operational Beds 909 971 2,461 2,486 3,370 3,457 ALOS (Days) 1.9 2.5 3.5 3.5 2.9 3.1 Occupancy 50% 57% 58% 44% 56% 47% Outpatient Visits ~
Slide 24: Segmental Performance FY21-Q1
Segmental Performance FY21-Q1 Growth % India - Unallocated India - Unallocated GCC GCC GCC GCC FY21 Q1 GCC Clinics Hospitals & & Total GCC Clinics Hospitals & & Total Hospitals Pharmacies Hospitals Pharmacies Clinics Eliminations Clinics Eliminations No. of Business Units (#) 13 107 238 H-13, C-9 NA
Slide 25: Maturity Wise Hospital Performance – GCC FY21 Q1
Maturity Wise Hospital Performance – GCC FY21 Q1 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 11% 17% ₹10 3 55% 12.8% 0-3 Years ₹ 75 162 ₹ ~113,100 Over 3 Years 89% 83% ₹ ~139,500 57% ₹93 10 ₹ 611 809 15.1% 13 ₹ 68
Slide 26: Maturity Wise Hospital Performance – India FY21 Q1
Maturity Wise Hospital Performance – India FY21 Q1 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 15% 13% ₹1 0-3 Years 2 ₹ ~24,880 60% 1.8% ₹ 45 331 Over 3 Years 85% 87% ₹ ~30,590 41% ₹18 10 ₹250 2,155 7.1% 12 ₹ 295
Slide 27: Financial Summary – Profitability Statement
Financial Summary – Profitability Statement Particulars (INR Cr) FY20 Q4 FY20 Q1 FY21 Q1 Revenue from operations 2,301 2,029 1,761 As at Jun 30, Consolidated (INR Cr) Material consumption 697 627 584 2020 Doctors cost 487 465 369 Debt 2,763 Employee cost (excl. doctors) 423 406 374 Less: Cash, Bank
Slide 28: Strategy and Leadership
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 27
Slide 29: ADMHL – Strategy & Outlook (1/2)
ADMHL – Strategy & Outlook (1/2) Strengthening of hub and A comprehensive human Scalable systems Strengthening of our medical spoke model in GCC resource strategy utilizing our implementation, tightly tourism network geographical diversity and integrated with catering to future growth operations/mar
Slide 30: ADMHL – Strategy & Outlook (2/2)
ADMHL – Strategy & Outlook (2/2) Profitability growth & brand Building of brand, talent Specialized, asset-light Cost Optimization positioning using product- and capability in KSA – a growth in India mix and technology key market in GCC • Focus on margin expansion through • There is significant dema
Slide 31: India Strategy
India Strategy India is geographically well positioned for Focus on In line with medical tourism focus on large format from the GCC hospitals in Tier 1 derisking states, MENA business – cities – Hospitals region and South- in Tier 1 cities The new National Health Protection Scheme target of 25% East
Slide 32: Aster Leadership Team
Aster Leadership Team Jobilal M. Vavachan Veneeth Purushotaman Dr. Azad Moopen Chief Executive Officer, Aster Chairman and Managing Director Group Chief Information Officer Primary Care Alisha Moopen Dr. Harish Pillai Fara Siddiqi Deputy Managing Director Chief Executive Officer –Aster India Group C
Slide 33: Aster Board of Directors
Aster Board of Directors strategy andleadership Dr. Azad Moopen C. John George Suresh M. Kumar Chairman and Managing Director Independent Director Independent Director Dr Layla Mohamed Biju Varkkey Alisha Moopen Deputy Managing Director Al-Marzooqi Independent Director Independent Director Daniel Ro
Slide 34: www.asterdmhealthcare.com
www.asterdmhealthcare.com